Bought Aastrom Biosciences; StemCells Inc. Spikes Up

Aastrom Biosciences (ASTM) continues to languish below $2, so I added to our ASTM holding buying shares at $1.63. I bought some ASTM early last month (on 02012.08.09) at $1.75. 52-week range: $1.52 - $2.91.

StemCells (STEM) spiked today after the company issued a press release having the following headline: "StemCells, Inc. Achieves Spinal Cord Injury Milestone With First Neural Stem Cell Transplant Into Patient With Sensory Function Below the Level of Injury". STEM closed yesterday (02012.09.26) at $1.93. Earlier today (02012.09.27) STEM hit $2.27. 52-week range: $0.59 - $2.67. With an hour left in trading, STEM volume was 10.1 million vs. trailing-3-month average of 2.6 million.